APOL1 and chronic kidney disease: Since classical CKD-FSGS occurs in only 4% of individuals carrying APOL1 variants, a theory was proposed that a second hit or exposure to an adverse milieu is required to escalate the expression of APOL1 variants for an optimal time and/or create a hostile environment that is adverse to podocyte health [28].